Capricor Therapeutics, Inc. Profile Avatar - Palmy Investing

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an…

Biotechnology
US, San Diego [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CAPR's Analysis
CIK: 1133869 CUSIP: 14070B309 ISIN: US14070B3096 LEI: - UEI: -
Secondary Listings
CAPR has no secondary listings inside our databases.